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ABSTRACT
The global pandemic of COVID-19 has challenged the 
management of hypoxaemic respiratory failure and 
strained intensive care unit resources. While prone 
positioning (PP) is an established therapy in mechanically 
ventilated patients with acute respiratory distress 
syndrome (ARDS), its role in conscious patients is less 
well defined. We retrospectively reviewed our experience 
of implementing early PP in a cohort of 24 patients with 
acute hypoxaemic respiratory failure due to COVID-19 who 
required support with continuous positive airway pressure 
(CPAP). The use of PP alongside CPAP significantly 
increased both the ROX index and arterial oxygen 
pressure:fractional inspired oxygen (PaO2:FiO2) ratio from 
baseline values (ROX index: 7.0±2.5 baseline vs 11.4±3.7 
CPAP+PP, p<0.0001; PaO2:FiO2 ratio: 143±73 mm Hg 
baseline vs 252±87 mm Hg CPAP+PP, p<0.01), and 
the changes to both the ROX index and PaO2:FiO2 ratio 
remained significant 1 hour after cessation of proning. 
The mean duration of PP in the first 24 hours was 
8±5 hours. Few complications were observed and PP was 
continued for a mean of 10±5 days. From our experience 
in a dedicated COVID-19 respiratory high care unit, PP 
alongside CPAP therapy was feasible, tolerated, safe and 
improved oxygenation. The use of conscious PP in ARDS 
warrants further investigation in randomised controlled 
trials.
INTRODUCTION
The COVID-19 pandemic has challenged 
the management of hypoxaemic respiratory 
failure, as limited intensive care capacity 
is strained by a novel disease with a high 
mortality and large numbers of patients 
requiring prolonged periods of invasive 
ventilation. While early and prolonged 
prone positioning (PP) reduces mortality 
in invasively ventilated patients with acute 
respiratory distress syndrome (ARDS),1 its 
role in conscious patients is uncertain. PP 
improves the homogeneity of lung aeration 
through recruitment of dorsal lung segments, 
reducing ventilation–perfusion mismatch, 
and ameliorates the high transpulmonary 
pressure variations and regional hyperinfla-
tion that exacerbate lung injury.1
Few studies have examined the physiolog-
ical effects of conscious PP in ARDS,2–5 and 
this strategy has not been widely adopted. 
Reports have shown improved respiratory 
parameters with conscious PP in COVID-19 
associated ARDS,6–8 and two groups have 
studied its use alongside non- invasive ventila-
tion.7 8 However, the reported duration of PP 
was short and there remain few studies of its 
application outside an intensive care setting.
At the onset of the COVID-19 pandemic, 
we established a designated COVID-19 respi-
ratory high care unit at the Bristol Royal 
Infirmary. This unit managed patients with 
ARDS due to COVID-19, both those in whom 
CPAP was a ceiling of therapy and those who 
were candidates for invasive ventilation. We 
adopted a policy of early conscious PP in 
patients with COVID-19 associated ARDS 
requiring CPAP and conducted a retrospec-
tive review of our experience, reporting the 
physiological changes, alongside the duration 
and tolerance of PP.
METHODS
Twenty- eight patients with ARDS due to severe 
acute respiratory syndrome coronavirus 2 
(SARS- CoV-2), confirmed on nasopharyngeal 
swab, admitted between 8th April and 31st 
May 2020 required CPAP and were assessed 
for PP. CPAP was indicated if arterial oxygen 
saturations were maintained less than 94% 
or there was respiratory distress, despite the 
delivery of high concentration supplemental 
oxygen therapy. Four patients were excluded 
from PP due to contraindications (imminent 
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intubation, reduced conscious level, significant immo-
bility or current pressure areas).
Patients received verbal and written information on 
the rationale and practicalities of PP, and patient posi-
tioning was recorded at least hourly. Physiological 
parameters were recorded immediately prior to CPAP 
initiation, while on CPAP prior to PP, during PP on CPAP 
(15 minutes after PP initiation) and 1 hour after PP while 
on CPAP.
Arterial oxygen saturations (SpO2) were measured by 
pulse oximetry. The arterial oxygen pressure:fractional 
inspired oxygen (PaO2:FiO2) ratio
9 and ROX index, a 
composite measure of oxygenation and work of breathing 
(ROX index=[SpO2/FiO2]/respiratory rate),
10 was calcu-
lated at each time point. The chest radiograph most 
recently performed prior to the initiation of CPAP was 
graded by an independent thoracic radiologist to assess 
the extent of consolidation. This was combined with the 
PaO2:FiO2 index and positive end- expiratory pressure 
required to maintain adequate oxygenation to calculate 
the Murray Lung Injury Score.11
The duration of PP achieved in the first 24 hours, 
number of consecutive days PP was adopted, nature of 
the PP (full or semiprone) and any complications were 
obtained from review of the medical records. Patient 
outcomes are reported at 28 days post admission. The 
research and development department of the University 
Hospitals Bristol and Weston Trust approved the retro-
spective data collection from electronic observations and 
case notes, and further analysis of this cohort. As a service 
evaluation, using routinely collected patient data held in 
an anonymised database, informed consent and approval 
of a research ethics committee were not required.
Analysis of variance with post hoc correction for multiple 
testing was used to compare ROX and PaO2:FiO2 indices 
at each time point, with statistical analysis conducted 
using GraphPad Prism (GraphPad Software, San Diego, 
California, USA). A p value <0.05 was considered statisti-
cally significant.
RESULTS
The patients’ characteristics are summarised in table 1. 
All 24 subjects had hypoxaemic respiratory failure and 
received CPAP to maintain adequate oxygenation, 
with none requiring bi- level pressure support. Of the 
24 subjects, 2 failed to tolerate PP, 1 due to worsening 
oxygenation and 1 due to pain. PP was initiated a median 
of 30 (IQR 7–99) hours after the commencement of 
CPAP, and the mean duration of PP in the first 24 hours 
was 8±5 hours. PP was continued for a mean of 10±5 
days. No sedation or anxiolytics were required to tolerate 
PP. Patients required the assistance of one nursing staff 
member to prone with the exception of one subject with 
a previous limb amputation. 12 patients adopted a full 
prone position, and the remaining 10 were semiprone 
in a lateral position due to discomfort caused by a fully 
prone position.
There was no significant difference in the measured 
respiratory rate at each time point (baseline 27±6 breaths/
min; CPAP 25±6 breaths/min; PP on CPAP 24±6 breaths/
min; post- PP 25±6 breaths/min; p=0.24). The mean arte-
rial oxygen saturation increased once CPAP therapy 
started although was not statistically different from base-
line levels (baseline 94±3% vs CPAP 95%±2%; p=0.23). 
Once PP was adopted on CPAP therapy, the mean arterial 
oxygen saturation was significantly different from base-
line levels (baseline 94%±3% vs PP on CPAP 96%±2%; 
p<0.005), and this difference was sustained 1 hour after 
cessation of PP (baseline 94%±3% vs post- PP 96%±2%; 
p<0.05).
The ROX index at each time point is shown in figure 1. 
There was a significant increase in the ROX index only 
once PP was adopted on CPAP from baseline values 
(baseline 7.0±2.5 vs PP on CPAP 11.4±3.7; p<0.0001), 
Table 1 Baseline characteristics of the patients with 
COVID-19 ARDS who received CPAP and attempted 
conscious PP (n=24)
Characteristics Value
Age, years 62 (13)
Male sex, n (%) 15 (63)
Coexisting conditions, n (%)
  Diabetes 7 (29)
  Hypertension 13 (54)
  Renal failure 2 (8)
  COPD 0 (0)
  Heart failure 1 (4)
  Cancer 2 (8)
Immunodeficiency, n (%) 2 (8)
APACHE II score 11 (5)*
CFS 2 (1–3)
ROX index prior to CPAP 6.8 (2.5)
PaO2:FiO2 prior to CPAP, mm Hg 112 (106–194)
ARDS severity classification, n (%)
  <100 (severe) 5 (21)
  100–200 (moderate) 14 (58)
  200–300 (mild) 3 (13)
  >300 2 (8)
Murray Lung Injury Score 2.7 (2.7–3.0)
Maximum PEEP required, cmH2O 12 (12–15)
Maximum FiO2 required 0.60 (0.50–0.70)
Data are shown as number (%) for categorical variables and mean 
(SD) or median (IQR).
*Insufficient data meant the APACHE II score could not be 
calculated in six patients.
APACHE, Acute Physiology and Chronic Health Evaluation; ARDS, 
acute respiratory distress syndrome; CFS, Clinical Frailty Score; 
COPD, chronic obstructive pulmonary disease; CPAP, continuous 
positive airway pressure; FiO2, fractional inspired oxygen; PaO2, 
arterial oxygen pressure; PEEP, positive end- expiratory pressure; 
PP, prone positioning.
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this difference being non- significant on CPAP therapy 
alone (baseline 7.0±2.5 vs CPAP 8.9±3.2; p=0.31). The 
increase in the ROX index from baseline was maintained 
1 hour after cessation of PP (baseline 7.0±2.5 vs post- PP 
10.3±3.5; p<0.01). The use of PP alongside CPAP signifi-
cantly increased the PaO2:FiO2 ratio from baseline values 
(baseline 143±73 mm Hg vs PP on CPAP 252±87 mm 
Hg; p<0.01), the difference in the PaO2:FiO2 ratio being 
non- significant between baseline and CPAP therapy 
alone (baseline 143±73 mm Hg vs CPAP 201±70 mm Hg; 
p=0.34). The increase in the PaO2:FiO2 ratio remained 
significant 1 hour after cessation of proning (baseline 
143±73 mm Hg vs post- PP 234±107 mm Hg; p<0.05) 
(figure 2). An improvement in ROX and PaO2:FiO2 
indices was observed for all ARDS severities. There were 
no significant differences between the changes from 
baseline in ROX index or PaO2:FiO2 ratio between those 
who adopted full PP versus those who were only able to 
adopt a semiprone position on CPAP (ΔROX index full 
PP 5±5 vs semiprone 4±3; p=0.46; ΔPaO2/FiO2 ratio full 
PP 124±84 mm Hg vs semiprone 90±89 mm Hg; p=0.38).
Apart from the 2 patients unable to tolerate PP, no 
complications were recorded. At 28 days post admis-
sion, 19 patients had been weaned off CPAP and 18 
discharged, with 1 remaining as an inpatient. 1 patient 
proceeded to invasive ventilation, from the subgroup 
of 14 patients in whom this was appropriate, and this 
patient was later discharged from the intensive care unit. 
4 patients had died by day 28 postadmission, of these 3 
had significant cardiorespiratory comorbidities and Clin-
ical Frailty Scores ranging from 4 to 6. The remaining 
patient presented with a new acute haematological malig-
nancy at the time of his presentation with COVID-19 asso-
ciated ARDS and was assessed alongside an intensive care 
physician and deemed not suitable for invasive mechan-
ical ventilation.
DISCUSSION
This retrospective review adds to the growing evidence 
that conscious PP may have a role in the management of 
ARDS in the context of COVID-19 infection. It supports 
previous findings in this group4 8 and does so across a 
range of ARDS severities and was delivered effectively 
outside of an intensive care setting.
PP in mechanically ventilated patients with ARDS 
requires the concomitant use of sedative and frequently 
neuromuscular blocking agents, with pressure sores and 
compressive neuropathies being recognised compli-
cations. In this retrospective review few complications 
were noted, even during more prolonged periods of PP 
than previously reported in conscious patients,5 7 8 and 
when this was performed over several consecutive days. 
Conscious patients were able to adjust their position when 
prone which likely contributes to the reduced complica-
tion rate seen. The use of conscious PP alongside CPAP 
therapy was both feasible and tolerated in a ward envi-
ronment with few resource requirements. This contrasts 
to invasively ventilated patients and the high resource 
intensity proning this group inherently entails. This has 
important implications in the management of ARDS 
when intensive care resources may be overwhelmed by 
Figure 1 ROX scores prior to continuous positive airway 
pressure (CPAP) (baseline), following CPAP initiation 
(CPAP), prone positioning on CPAP (CPAP+PP) and 1 hour 
after cessation of proning while on CPAP (post). Analysis 
of variance with correction for multiple testing was used to 
compare each time point. *Significantly different from CPAP, 
p<0.05. †Significantly different from baseline, p<0.0001. 
#Significantly different from baseline, p<0.01.
Figure 2 Arterial oxygen pressure:fractional inspired 
oxygen (PaO2:FiO2) ratios prior to continuous positive 
airway pressure (CPAP) (baseline), following CPAP initiation 
(CPAP), prone positioning on CPAP (CPAP+PP) and 1 hour 
after cessation of proning while on CPAP (post). Analysis 
of variance with correction for multiple testing was used 
to compare each time point. †Significantly different from 
baseline, p<0.01. #Significantly different from baseline, 
p<0.05.
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demand, as has occurred in many healthcare systems 
managing COVID-19. While we note that this cohort is 
likely to be underpowered to detect significant differ-
ences due to the position adopted during conscious 
PP, it is interesting to note that even in those adopting 
a semiprone position physiological improvements were 
still observed. Thus, the inability to adopt a full prone 
position should not deter from attempts to prone.
In spontaneously breathing patients with ARDS patient- 
induced lung injury is hypothesised to be important in 
its progression. The ROX index has been validated in 
patients with ARDS treated with nasal high flow oxygen 
therapy,10 and provides a composite of both oxygenation 
and work of breathing. The reduction of the ROX index 
achieved by PP on CPAP may suggest that use of this 
treatment modality could avoid further disease progres-
sion by reducing work of breathing. Further studies to 
validate the role of the ROX index in patients with ARDS 
receiving CPAP are required; however, this index may be 
helpful to describe the ARDS population given that high 
transpulmonary pressure swings that occur with a high 
work of breathing is noted to exacerbate the underlying 
lung injury.1
The improvement in respiratory parameters achieved by 
PP on CPAP provides a potential alternative to increasing 
the positive end- expiratory pressure, which may be both 
poorly tolerated in conscious patients and may exacer-
bate the lung injury through barotrauma. The evidence 
from invasively ventilated patients with ARDS shows that 
early, prolonged PP is crucial to its success1 and we were 
able to institute PP early after CPAP commencement and 
for long periods in conscious patients.
This study has limitations being an uncontrolled, non- 
randomised study, with a small sample size that may be 
prone to bias and no formal proning protocol. However, 
it adds to a body of evidence that physiological benefits 
are demonstrated and prospective randomised controlled 
studies of conscious PP in this group are warranted. 
Important research questions remain about whether PP 
can be considered as a ‘preventative’ rather than ‘rescue’ 
therapy in ARDS, delaying or avoiding mechanical venti-
lation and improving associated morbidity and mortality.
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